-
Published 5/26/2026
Lu S, Karkempetzaki AI, Huang N, Zhang C, Murphy GJ, Ravid K. Hematopoietic JAK2V617F mutation-induced reprogramming of blood and bone marrow megakaryocytes. Blood Adv. 2026 May 26; 10(10):3437-3441. PMID: 41707101.
-
Published 5/18/2026
He T, Zheng C, La J, Pham D, Jafari O, Strampe J, Dulberger K, Ramos-Cejudo J, Gaziano JM, Do NV, Chitalia V, Ravid K, Li A, Fillmore NR. A deep learning model to dynamically predict cancer-associated thromboembolism in large-scale healthcare systems. NPJ Digit Med. 2026 May 18. PMID: 42151458.
-
Published 1/5/2026
Subramaniam S, Napoleon MA, Lotfollahzadeh S, Kamal MH, Kurniawan H, Francis C, Elsadawi M, Wu Wong DJ, Kenney D, Douam F, Bosmann M, Whelan SA, Cabral H, Burks EJ, Zhao G, Kolachalama VB, Ravid K, Chitalia VC. Tryptophan metabolism reprogramming potentially contributes to the prothrombotic milieu in mice and humans with SARS-CoV-2. Blood Vessel Thromb Hemost. 2026 Feb; 3(1):100128. PMID: 41743170.
-
Published 12/16/2025
Singh SV, Karkempetzaki AI, Huang N, Chitalia VC, Subramaniam S, Ravid K. Piezo1 Mechanosensor Expression in Rare Hematopoietic Cells Controls Systemic Inflammatory Response in Mice. Cells. 2025 Dec 16; 14(24). PMID: 41440018.
-
Published 12/5/2025
Jose A, Lu S, Zhang C, La J, Young M, Gaziano JM, Fillmore NR, Ravid K, Chitalia VC. A panel of plasma proteins associated with venous thromboembolism in patients with prostate cancer. Cancer Biomark. 2025 Dec; 42(12):18758592251390251. PMID: 41348521.